Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002550567 | SCV001129751 | benign | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | 2023-10-09 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV002550567 | SCV003830256 | uncertain significance | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | 2021-06-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003906110 | SCV004724803 | benign | CA5A-related disorder | 2019-11-16 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |